Alain Puisieux

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Olivier Delattre, 2008, Nature.

Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells

Florence Le Calvez-Kelm, Sean V Tavtigian, Zdenko Herceg, 2011, Epigenetics.

p53 as a target for anti-cancer drug development.

B. Bouchet, C. Caron de Fromentel, A. Puisieux, 2006, Critical reviews in oncology/hematology.

Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines

Jingwei Ji, Mehmet Ozturk, Cengiz Yakicier, 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition

A. Puisieux, A. Morel, S. Ansieau, 2008, PloS one.

Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing

Qing Wang, Valérie Bonadona, J. Saurin, 2006, Human mutation.

Metastasis: a question of life or death

A. Puisieux, P. Mehlen, Alain Puisieux, 2006, Nature Reviews Cancer.

Real-time PCR based on SYBR-Green I fluorescence: An alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions

Valerie Combaret, John D Isaacs, Carmel Toomes, 2003, BMC biotechnology.

ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors

Marie Perier-Muzet, Maxime Battistella, Arnaud de la Fouchardière, 2016, EMBO molecular medicine.

Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma

Gudrun Schleiermacher, Olivier Delattre, David Gentien, 2016, Clinical Cancer Research.